Skip to main content
. 2017 Dec 4;9(3):3922–3935. doi: 10.18632/oncotarget.22883

Figure 2. Myosin phosphatase components are dysregulated in prostate cancer.

Figure 2

Expression of PPP1R14C and PPP1R12A is evaluated in 4 publicly available prostate cancer datasets.